Development of a core outcome set for use in adult primary glioma phase III interventional trials: A mixed methods study.
Ameeta RetzerElin BaddeleyStephanie SivellHannah ScottAnnmarie NelsonHelen BulbeckKathy SeddonRobin GrantRichard AdamsColin WattsOlalekan Lee AiyegbusiPamela KearnsSamantha Cruz RiveraLinda DirvenMelanie CalvertAnthony ByrnePublished in: Neuro-oncology advances (2023)
A COS for glioma trials was developed, comprising 7 outcome domains. Additional research will identify appropriate measurement tools and further validate this COS.